LINC02082: A Potential Drug Target and Biomarker (G100507661)

Target Name: LINC02082

NCBI ID: G100507661

LINC02082

Other Name(s): Long intergenic non-protein coding RNA 2082 | long intergenic non-protein coding RNA 2082

LINC02082: A Potential Drug Target and Biomarker

LINC02082 is a novel non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is derived from the long non-coding RNA (lnc) domain and has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. LINC02082 has also been shown to be involved in the regulation of cell cycle progression and has been linked to the development and progression of various diseases, including cancer.

The LINC02082 gene has four exons, which encode a protein with potential drug target properties. The first exon encodes a protein that contains a unique farnesylated cysteine residue, which is known to be a target for small molecules. The second exon encodes a protein that contains a unique lysine residue, which is also known to be a target for small molecules. The third exon encodes a protein that contains a unique arginine residue, which is known to be a target for small molecules. The fourth exon encodes a protein that contains a unique cysteine residue, which is known to be a target for small molecules.

Preclinical studies have shown that LINC02082 can be inhibited by small molecules, which suggests that it may be a potential drug target. In addition, studies have also shown that LINC02082 is involved in the regulation of cell cycle progression and that it is associated with the development and progression of various diseases, including cancer. These findings suggest that LINC02082 may be a valuable biomarker for the diagnosis and treatment of cancer.

In conclusion, LINC02082 is a novel non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its unique farnesylated cysteine residue and lysine residue, as well as its role in the regulation of cell cycle progression and its association with the development and progression of various diseases, make it a promising candidate for further investigation. Further studies are needed to determine the full potential of LINC02082 as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2082

The "LINC02082 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02082 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets